CELLULAR THERAPEUTICS IN TRAUMA AND CRITICAL CARE

The goal of this meeting is to bring together the expertise and input of blood bankers, clinicians, basic scientists, industry, FDA, NIH, AABB, and DoD representatives to discuss existing barriers in the translation of these novel therapies in trauma and critical care, fields with limited new therapeutic options and unlimited opportunities for advancement. This is an exclusive meeting with limited attendees to foster in depth interactions and collaboration. Our speakers are leaders in their fields and have diverse expertise and knowledge in these areas. Our target audience includes clinicians, physician-scientists, basic scientists and industry leaders who are interested in the field, currently working in or anticipate working in the field of novel therapeutics for critically ill patients.